IRIS
MATERA, Maria Gabriella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 18.184
NA - Nord America 9.673
AS - Asia 8.407
SA - Sud America 1.515
Continente sconosciuto - Info sul continente non disponibili 405
AF - Africa 100
OC - Oceania 11
Totale 38.295
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 11.389
US - Stati Uniti d'America 9.483
SG - Singapore 3.378
IE - Irlanda 1.959
CN - Cina 1.594
HK - Hong Kong 1.538
BR - Brasile 1.285
UA - Ucraina 1.122
IT - Italia 908
GB - Regno Unito 896
VN - Vietnam 849
DE - Germania 764
FI - Finlandia 289
KR - Corea 279
FR - Francia 265
GR - Grecia 223
SE - Svezia 191
TR - Turchia 185
IN - India 183
JP - Giappone 104
AR - Argentina 78
CA - Canada 67
MX - Messico 55
BD - Bangladesh 52
ID - Indonesia 43
IQ - Iraq 38
EC - Ecuador 37
NL - Olanda 31
CO - Colombia 27
BE - Belgio 26
CL - Cile 24
ZA - Sudafrica 23
ES - Italia 22
UZ - Uzbekistan 20
PK - Pakistan 19
VE - Venezuela 19
MA - Marocco 18
PY - Paraguay 18
AT - Austria 17
PE - Perù 17
PL - Polonia 15
DZ - Algeria 13
IL - Israele 13
JM - Giamaica 13
CR - Costa Rica 12
MY - Malesia 12
MD - Moldavia 11
EG - Egitto 10
TH - Thailandia 10
TW - Taiwan 10
AE - Emirati Arabi Uniti 8
AU - Australia 8
EU - Europa 8
IR - Iran 8
NI - Nicaragua 8
SA - Arabia Saudita 8
TN - Tunisia 8
BG - Bulgaria 7
DO - Repubblica Dominicana 7
ET - Etiopia 7
HN - Honduras 7
KE - Kenya 7
AL - Albania 6
CH - Svizzera 6
CZ - Repubblica Ceca 6
NP - Nepal 6
PH - Filippine 6
BB - Barbados 5
CI - Costa d'Avorio 5
LB - Libano 5
PT - Portogallo 5
UY - Uruguay 5
AZ - Azerbaigian 4
OM - Oman 4
TT - Trinidad e Tobago 4
BH - Bahrain 3
BO - Bolivia 3
BY - Bielorussia 3
HR - Croazia 3
JO - Giordania 3
KG - Kirghizistan 3
KZ - Kazakistan 3
LT - Lituania 3
NZ - Nuova Zelanda 3
PS - Palestinian Territory 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
AP - ???statistics.table.value.countryCode.AP??? 2
EE - Estonia 2
GE - Georgia 2
GT - Guatemala 2
GY - Guiana 2
PA - Panama 2
PR - Porto Rico 2
QA - Qatar 2
RS - Serbia 2
SC - Seychelles 2
SN - Senegal 2
SV - El Salvador 2
TM - Turkmenistan 2
Totale 37.874
Salva come PNG Salva come JPEG
Città #
Moscow 4.002
Dublin 1.955
Jacksonville 1.717
Hong Kong 1.520
Santa Clara 1.419
Singapore 1.335
San Jose 997
Chandler 756
Ashburn 525
Princeton 359
Medford 326
Ho Chi Minh City 275
Seoul 263
Bremen 225
Hefei 211
Hanoi 203
Roxbury 188
Boardman 183
Beijing 172
San Mateo 158
The Dalles 149
Bengaluru 139
Wilmington 139
Council Bluffs 119
Ann Arbor 102
Woodbridge 86
Dallas 82
Cambridge 77
Des Moines 72
São Paulo 72
Naples 69
New York 60
Da Nang 59
Düsseldorf 49
Los Angeles 48
Caserta 42
Haiphong 42
Rio de Janeiro 38
Rome 38
Orem 36
Shanghai 36
Munich 34
Norwalk 34
Jinan 33
Atlanta 25
Milan 25
Nanjing 25
Brussels 24
Curitiba 23
Frankfurt am Main 23
Hải Dương 23
Biên Hòa 22
Guangzhou 22
Brasília 21
Tokyo 21
Tashkent 20
Falkenstein 19
Houston 19
Memphis 19
Zhengzhou 19
Belo Horizonte 18
Changsha 18
Guarulhos 18
Hebei 18
Montreal 18
Napoli 18
Phoenix 18
Nuremberg 17
Campinas 16
Mexico City 16
Mountain View 16
Porto Alegre 16
San Potito Sannitico 16
Shenyang 16
Dhaka 15
Redwood City 15
Salvador 15
San Marcellino 15
Turku 15
Bari 14
Shenzhen 14
Baghdad 13
Brooklyn 13
Goiânia 13
London 13
Osasco 13
Auburn Hills 12
Haikou 12
Amsterdam 11
Bắc Ninh 11
Canoas 11
Dearborn 11
Florence 11
Guayaquil 11
Hangzhou 11
Lima 11
Ninh Bình 11
San Francisco 11
Seattle 11
Sorocaba 11
Totale 19.357
Salva come PNG Salva come JPEG
Nome #
Farmaci dell’Apparato Respiratorio: Regolazione del tono broncomotore. 399
Sistema purinergico. 365
The effect of N-acetylcysteine on biofilms: Implications for the treatment of respiratory tract infections 256
“COPDCoRi: applicazione non invasiva per la stima e la previsione del rischio di patologia coronarica nei pazienti affetti da broncopneumopatia cronica ostruttiva (BPCO)”. 183
Effects of chronic administration of β-blockers on airway responsiveness in a murine model of heart failure. 180
Antiflammins suppress the A23187- and arachidonic acid-dependent chloride secretion in rabbit distal colonic mucosa 180
Effects of chronic treatment with the new ultra-long-acting β2 -adrenoceptor agonist indacaterol alone or in combination with the β1 -adrenoceptor blocker metoprolol on cardiac remodelling. 174
10. Aclidinium bromide/formoterol fumarate fixed-dose combination for the treatment of chronic obstructive pulmonary disease. 174
Aclidinium bromide inhalation powder for the long-term, maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease including chronic bronchitis and emphysema 172
ACE2: The Major Cell Entry Receptor for SARS-CoV-2 170
Amminoacidi eccitatori e regolazione centrale della funzione cardiovascolare: contributi sperimentali. 165
Brain natriuretic peptide : much more than a biomarker 162
Severe respiratory SARS-CoV2 infection: Does ACE2 receptor matter? 158
Effect of hyperbaric oxygen therapy in experimental subcutaneous and pulmonary infections due to Pseudomonas aeruginosa 154
A comparison of sensory nerve function in human, guinea-pig, rabbit and marmoset airways 152
1. New developments in the combination treatment of COPD: focus on umeclidinium/vilanterol. 151
A single high dose of formoterol is as effective as the same dose administered in a cumulative manner in patients with acute exacerbation of COPD 148
Sirtuins and Cellular Senescence in Patients with Idiopathic Pulmonary Fibrosis and Systemic Autoimmune Disorders 147
Calcium dependence of the evoked arginine vasopressin release by electrical stimulation and by L-glutamate 147
Acute effects of higher than customary doses of salmeterol and salbutamol in patients with acute exacerbation of COPD. 146
A comparison of the bronchodilating effects of salmeterol, salbutamol and ipratropium bromide in patients with chronic obstructive pulmonary disease 144
Assessing the viability of long-acting β(2)-agonists in paediatric asthma patients: a pharmacokinetic/pharmacodynamic perspective. 144
Aclidinium bromide for the treatment of chronic obstructive pulmonary disease. 142
Characterization of adenosine receptors involved in adenosine-induced bronchoconstriction in allergic rabbits 142
A combination with clinical recommended dosages of salmeterol and ipratropium is not more effective than salmeterol alone in patients with chronic obstructive pulmonary disease 141
5-HT modifiers as a potential treatment of asthma 138
Animal models of chronic obstructive pulmonary disease and their role in drug discovery and development: a critical review 138
An update on the currently available and emerging synthetic pharmacotherapy for uncontrolled asthma 137
Farmaci del sistema cardiovascolare, del sangue e del rene 136
Excitatory amino acids and cardiovascular apparatus: experimental studies on conscious rats with L-glutamate, N-methyl-D-aspartate, kainate and quisqualate 135
A comparison of bronchodilating effects of salmeterol and oxitropium bromide in stable chronic obstructive pulmonary disease 135
A review of the pharmacokinetics of M3 muscarinic receptor antagonists used for the treatment of asthma 135
Protein Prenylation Contributes to the Effects of LPS on EFS-Induced Responses in Human Isolated Bronchi 134
The anti-proliferative effects of adiponectin on human lung adenocarcinoma A549 cells and oxidative stress involvement 134
Effects of hyperbaric oxygen exposure on non-adrenergic non-cholinergic responses of rat trachea 133
[The therapeutic prospects of ischemic cardiopathy] 133
Contribution of sensory nerves to LPS-induced hyperresponsiveness of human isolated bronchi. 132
. Brain natriuretic peptide modulates calcium homeostasis and epidermal growth factor receptor gene signalling in asthmatic airways smooth muscle cells. 131
A safety comparison of LABA+LAMA vs LABA+ICS combination therapy for COPD 131
Pulmonary penetration of dirithromycin in patients suffering from acute exacerbation of chronic bronchitis 128
K+ channels and guinea-pig trachea: a possible functional modulation by GABAB receptors 128
Research on heterocyclic compounds. XIV - Imidazothiazole and imidazobenzothiazole derivatives: synthesis and antiinflammatory activity 127
Role of 5-hydroxytryptamine in mediating adenosine-induced airway contraction 127
Chronic obstructive pulmonary disease and coronary disease: COPDCoRi, a simple and effective algorithm for predicting the risk of coronary artery disease in COPD patients. 125
Bioavailability of timolol and aceclidine after ocular instillation in the rabbit 124
Effects of RO 5-4864 and PK 11195 on guinea pig trachea 124
Flomoxef, a new oxacephem antibiotic, does not cause hemostatic defects 124
N-acetylcysteine in COPD may be beneficial, but for whom? 124
A systematic review with meta-analysis of dual bronchodilation with LAMA/LABA for the treatment of stable COPD 124
A potential role of triple therapy for asthma patients 124
Pharmacological characterization of the interaction between the dual phosphodiesterase (PDE) 3/4 inhibitor RPL554 and glycopyrronium on human isolated bronchi and small airways. 123
A long-term clinical trial on the efficacy and safety profile of doxofylline in Asthma: The LESDA study 123
Ions and intracellular mechanisms involved in the effects of L-glutamate on arginine vasopressin release: in vitro researches on rat neurohypophysis 122
Effects of in vitro 5-HT1 receptor activation in guinea pig trachea 122
Evidence of muscarinic receptor subtypes in airway smooth muscle of normal volunteers and of chronic obstructive pulmonary disease patients 122
Drug-Drug Interactions and Synergy: From Pharmacological Models to Clinical Application 121
Umeclidinium bromide + vilanterol for the treatment of chronic obstructive pulmonary disease. 121
N-Acetylcysteine protects human bronchi by modulating the release of neurokinin A in an ex vivo model of COPD exacerbation. 121
Immune checkpoint inhibitors: a new landscape for extensive stage small cell lung cancer treatment 121
The additive effect of theophylline on a combination of formoterol and tiotropium in stable COPD: a pilot study 120
Prenatal and postnatal antimony exposure in rats: effect on vasomotor reactivity development of pups 118
Prenatal and postnatal vanadium exposure in rats: effect on vasomotor reactivity development of pups 118
Brain Natriuretic Peptide Protects Against Hyperreactivity of Human Asthmatic Airway Smooth Muscle via an Epithelial Cell Dependent Mechanism. 117
Treatment of COPD: moving beyond the lungs. 117
The burden of obesity in asthma and COPD: Role of adiponectin 117
Adding a LAMA to ICS/LABA therapy: a meta-analysis of triple therapy in COPD 117
Functional role of nitric oxide in guinea pig tracheal epithelium 116
Intraulmonary penetration of antimicrobials and implications in the treatment of lower respiratory tract infections. 116
Advances in the Pharmacological Management of Pediatric Acute Respiratory Distress Syndrome 116
Pharmacokinetic/pharmacodynamic drug evaluation of benralizumab for the treatment of asthma. 115
Evidence for non-adrenergic non-cholinergic contractile responses in bovine and swine trachea 115
characterization of the Pharmacological interaction between aclidinium bromide and formoterol fumarate on human isolated bronchi. 114
Treating systemic effects of COPD. 114
Terapie per i disordini labirintici: effetti e riflessi sulla pressione arteriosa 114
Pulmonary concentrations of dirithromycin and erythromycin during acute exacerbation of mild chronic obstructive pulmonary disease 113
Farmaci per il trattamento delle aritmie cardiache. 113
Translational Study Searching for Synergy between Glycopyrronium and Indacaterol. 112
Farmaci per il trattamento della cardiopatia ischemica. 112
Current pharmacotherapeutic options for pediatric lower respiratory tract infections with a focus on antimicrobial agents 111
I farmaci del sistema nervoso centrale 111
Pirfenidone, nintedanib and N-acetylcysteine for the treatment of idiopathic pulmonary fibrosis: A systematic review and meta-analysis 111
Pharmacological treatment and current controversies in COPD 110
Tremor and β(2)-adrenergic agents: is it a real clinical problem? 110
Safety Considerations with Dual Bronchodilator Therapy in COPD: An Update 110
Bronchodilator response to formoterol Turbuhaler in patients with COPD under regular treatment with formoterol Turbuhaler 109
Possible functional modulation by acetylcholine of nitric oxide on guinea pig isolated trachea 109
Pharmacological Characterization of Adenosine Receptors on Isolated Human Bronchi 108
Role of 5-HT2 receptor subtypes in mediating adenosine-induced airway contraction 108
The ongoing challenge of prevention of pertussis in infants: what’s new in 2024? 107
Ondansetron, an antagonist of 5-HT3 receptors, in the treatment of antineoplastic drug-induced nausea and vomiting in children 107
Muscarinic receptor antagonists for the treatment of chronic obstructive pulmonary disease. 107
Theophylline in the inhibition of angiotensin-converting enzyme inhibitor-induced cough 107
Nitric oxide regulatory role in sensitized guinea pig trachea 107
Impact of erdosteine on chronic bronchitis and COPD: A meta-analysis 107
Bronchodilator reversibility testing in post-COVID-19 patients undergoing pulmonary rehabilitation 107
Impact of biologics on lung hyperinflation in patients with severe asthma 106
Effect of telenzepine, an M1-selective muscarinic receptor antagonist, in patients with nocturnal asthma 106
Pulmonary disposition of lomefloxacin in patients with acute exacerbation of chronic obstructive pulmonary disease. A multiple-dose study 106
A comprehensive overview of investigational elastase inhibitors for the treatment of acute respiratory distress syndrome 105
Addition of an extra dose of salmeterol Diskus to conventional dose of salmeterol Diskus in patients with COPD 105
Totale 13.421
Salva come PNG Salva come JPEG
Categoria #
all - tutte 139.997
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 139.997
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.767 0 15 27 42 688 7 25 47 59 70 185 602
2022/20233.445 411 47 36 234 440 248 7 178 1.694 17 53 80
2023/20241.395 103 34 35 138 551 59 36 33 14 21 85 286
2024/20255.490 34 33 57 154 874 615 551 446 657 1.411 394 264
2025/202619.242 848 800 1.035 1.260 1.277 10.682 1.152 704 772 368 234 110
2026/2027851 207 644 0 0 0 0 0 0 0 0 0 0
Totale 38.295